Literature DB >> 34229835

Epidemiology of Alcohol-Associated Liver Disease.

Sen Han1, Zhihong Yang2, Ting Zhang2, Jing Ma2, Kristina Chandler2, Suthat Liangpunsakul3.   

Abstract

Alcohol-associated liver disease (ALD) is a consequence of excessive alcohol use. It comprises a spectrum of histopathologic changes ranging from simple steatosis, steatohepatitis, and cirrhosis to hepatocellular carcinoma. The public health impact of ALD is growing because of an increase in the prevalence and incidence of ALD in parallel with liver transplant and mortalities. There are multiple factors involved in the pathogenesis and progression of ALD. Reducing alcohol consumption is the cornerstone of ALD management. The efforts to reduce excessive alcohol use at the individual and population levels are urgently needed to prevent adverse outcomes from ALD.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic; Epidemiology; Liver diseases; Public health

Mesh:

Year:  2021        PMID: 34229835      PMCID: PMC8996817          DOI: 10.1016/j.cld.2021.03.009

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.265


  68 in total

1.  Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis.

Authors:  Thoetchai Bee Peeraphatdit; Patrick S Kamath; Victor M Karpyak; Brian Davis; Vivek Desai; Suthat Liangpunsakul; Arun Sanyal; Naga Chalasani; Vijay H Shah; Douglas A Simonetto
Journal:  Clin Gastroenterol Hepatol       Date:  2019-04-28       Impact factor: 11.382

Review 2.  Non-invasive diagnosis and biomarkers in alcohol-related liver disease.

Authors:  Christophe Moreno; Sebastian Mueller; Gyongyi Szabo
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

3.  Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States.

Authors:  Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2011-09       Impact factor: 3.062

4.  Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.

Authors:  Adeyinka C Adejumo; George Cholankeril; Umair Iqbal; Eric R Yoo; Brian C Boursiquot; Waldo C Concepcion; Donghee Kim; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2019-08-01       Impact factor: 3.199

5.  Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers.

Authors:  John B Whitfield; Steven Masson; Suthat Liangpunsakul; Sebastian Mueller; Guruprasad P Aithal; Florian Eyer; Dermot Gleeson; Andrew Thompson; Felix Stickel; Michael Soyka; Beat Muellhaupt; Ann K Daly; Heather J Cordell; Tatiana Foroud; Lawrence Lumeng; Munir Pirmohamed; Bertrand Nalpas; Jean-Marc Jacquet; Romain Moirand; Pierre Nahon; Sylvie Naveau; Pascal Perney; Paul S Haber; Helmut K Seitz; Christopher P Day; Philippe Mathurin; Timothy R Morgan; Devanshi Seth
Journal:  Am J Gastroenterol       Date:  2021-01-01       Impact factor: 10.864

Review 6.  Management of alcohol misuse in patients with liver diseases.

Authors:  Jennifer L Peng; Milan Prakash Patel; Breann McGee; Tiebing Liang; Kristina Chandler; Sucharat Tayarachakul; Sean O'Connor; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-12-09       Impact factor: 2.895

7.  Alcohol and cirrhosis: dose--response or threshold effect?

Authors:  Mads Kamper-Jørgensen; Morten Grønbaek; Janne Tolstrup; Ulrik Becker
Journal:  J Hepatol       Date:  2004-07       Impact factor: 25.083

8.  National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States.

Authors:  Brian P Lee; Eric Vittinghoff; Jennifer L Dodge; Giuseppe Cullaro; Norah A Terrault
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

9.  Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact on subsequent survival.

Authors:  H Innes; J R Morling; E A Aspinall; D J Goldberg; S J Hutchinson; I N Guha
Journal:  Public Health       Date:  2020-09-28       Impact factor: 2.427

10.  Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis.

Authors:  Milan Sheth; Mark Riggs; Tushar Patel
Journal:  BMC Gastroenterol       Date:  2002-01-22       Impact factor: 3.067

View more
  6 in total

Review 1.  Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.

Authors:  Sandra Torres; Paula Segalés; Carmen García-Ruiz; José C Fernández-Checa
Journal:  Cells       Date:  2022-04-27       Impact factor: 7.666

Review 2.  Pathogenesis of Alcohol-Associated Fatty Liver: Lessons From Transgenic Mice.

Authors:  Afroza Ferdouse; Robin D Clugston
Journal:  Front Physiol       Date:  2022-07-05       Impact factor: 4.755

3.  Telomere length in patients with alcohol-associated liver disease: a brief report.

Authors:  Nazmul Huda; Praveen Kusumanchi; Kristina Perez; Yanchao Jiang; Nicholas J Skill; Zhaoli Sun; Jing Ma; Zhihong Yang; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2022-03-04       Impact factor: 3.235

4.  Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora.

Authors:  Jiayue Liu; Lingzhou Kong; Mengting Shao; Changhai Sun; Changxu Li; Yanyan Wang; Xue Chai; Yuliang Wang; Yu Zhang; Xiaoliang Li; Hong Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

5.  Jia-ga-song-tang protection against alcoholic liver and intestinal damage.

Authors:  Jiamin Fang; Yuhuan Wu; Changlian Gan; Shufang Ruan; Xiaoliang He; Bixia Wang; Ying Wang; Jingtao Yu; Chuanlan Sang; Dawa Zeren; Tianqin Xiong
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

6.  Characteristics of patients with hepatocellular carcinoma: A multicenter study.

Authors:  Fatih Guzelbulut; Umit Karaogullarindan; Hikmet Akkiz; Engin Altintas; Coskun Ozer Demirtas; Ozgur Bahadir; Caglayan Keklikkiran; Abdullah Emre Yildirim; Mesut Gumussoy; Hatice Rizaoglu Balci; Pinar Gokcen; Dilara Turan Gokce; Cem Simsek; Ilker Turan; Guray Can; Volkan Gokbulut; Serkan Yaras; Gupse Adali; Remzi Adnan Akdogan; Ufuk Avcioglu; Mehmet Demir; Hamdi Levent Doganay; Sezgin Vatansever; Hale Sumer; Feyza Dilber; Meral Akdogan Kayhan; Hatice Yasemin Balaban; Halis Simsek; Osman Cavit Ozdogan; Ulus Salih Akarca; Zeki Karasu; Fulya Gunsar; Ramazan Idilman
Journal:  Hepatol Forum       Date:  2022-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.